John E. Kao - 13 Mar 2026 Form 4 Insider Report for Alignment Healthcare, Inc. (ALHC)

Reporting relationship: Chief Executive Officer, Director
Issuer ticker: ALHC
Reported as of: 13 Mar 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 17 Mar 2026, 17:13:32 UTC
Prior SEC filing: 13 Mar 2026
Next SEC filing: 19 Mar 2026
Source filing: View source filing
Reporting owner signature: /s/ Christopher J. Joyce, as Attorney-in-Fact, for John E. Kao

Key filing fact

John E. Kao filed Form 4 for Alignment Healthcare, Inc. (ALHC) on 17 Mar 2026.

Key facts

This page summarizes John E. Kao's Form 4 filing for Alignment Healthcare, Inc. (ALHC).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 17 Mar 2026, 17:13.

Change

Previous filing in this sequence was filed on 13 Mar 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001222028 Primary reporting owner

KAO JOHN E

Relationship: Chief Executive Officer, Director
Address: 1100 W. TOWN & COUNTRY RD., SUITE 1600, ORANGE
Signature: /s/ Christopher J. Joyce, as Attorney-in-Fact, for John E. Kao
Signature date: 17 Mar 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ALHC transaction

Common Stock

Award

Transaction value
Shares: +338,434
Change %: +22%
Price: $0.000000^*
Shares after: 1,857,914
Date: 13 Mar 2026
Ownership: Direct
Footnotes: F1

ALHC holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 2,472,641
Date: 13 Mar 2026
Ownership: See Footnote
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Represents 338,434 restricted stock units, each restricted stock unit representing the right to receive one share of Common Stock of the Company, that will vest approximately one third on each of the first three anniversaries of the grant date, subject to the reporting person's continued service to the Company as of the applicable vesting date.

Footnote F2

Represents securities held by JEK Trust, dated February 8, 2021, of which Mr. Kao is the trustee.